These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 34389065)

  • 1. Supratentorial non-RELA, ZFTA-fused ependymomas: a comprehensive phenotype genotype correlation highlighting the number of zinc fingers in ZFTA-NCOA1/2 fusions.
    Tauziède-Espariat A; Siegfried A; Nicaise Y; Kergrohen T; Sievers P; Vasiljevic A; Roux A; Dezamis E; Benevello C; Machet MC; Michalak S; Puiseux C; Llamas-Gutierrez F; Leblond P; Bourdeaut F; Grill J; Dufour C; Guerrini-Rousseau L; Abbou S; Dangouloff-Ros V; Boddaert N; Saffroy R; Hasty L; Wahler E; Pagès M; Andreiuolo F; Lechapt E; Chrétien F; Blauwblomme T; Beccaria K; Pallud J; Puget S; Uro-Coste E; Varlet P;
    Acta Neuropathol Commun; 2021 Aug; 9(1):135. PubMed ID: 34389065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supratentorial ependymoma in childhood: more than just RELA or YAP.
    Zschernack V; Jünger ST; Mynarek M; Rutkowski S; Garre ML; Ebinger M; Neu M; Faber J; Erdlenbruch B; Claviez A; Bielack S; Brozou T; Frühwald MC; Dörner E; Dreschmann V; Stock A; Solymosi L; Hench J; Frank S; Vokuhl C; Waha A; Andreiuolo F; Pietsch T
    Acta Neuropathol; 2021 Mar; 141(3):455-466. PubMed ID: 33481105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ependymoma-like tumor with mesenchymal differentiation harboring C11orf95-NCOA1/2 or -RELA fusion: A hitherto unclassified tumor related to ependymoma.
    Tomomasa R; Arai Y; Kawabata-Iwakawa R; Fukuoka K; Nakano Y; Hama N; Nakata S; Suzuki N; Ishi Y; Tanaka S; Takahashi JA; Yuba Y; Shiota M; Natsume A; Kurimoto M; Shiba Y; Aoki M; Nabeshima K; Enomoto T; Inoue T; Fujimura J; Kondo A; Yao T; Okura N; Hirose T; Sasaki A; Nishiyama M; Ichimura K; Shibata T; Hirato J; Yokoo H; Nobusawa S
    Brain Pathol; 2021 May; 31(3):e12943. PubMed ID: 33576087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging.
    Pagès M; Pajtler KW; Puget S; Castel D; Boddaert N; Tauziède-Espariat A; Picot S; Debily MA; Kool M; Capper D; Sainte-Rose C; Chrétien F; Pfister SM; Pietsch T; Grill J; Varlet P; Andreiuolo F
    Brain Pathol; 2019 May; 29(3):325-335. PubMed ID: 30325077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C11orf95-RELA fusions and upregulated NF-KB signalling characterise a subset of aggressive supratentorial ependymomas that express L1CAM and nestin.
    Malgulwar PB; Nambirajan A; Pathak P; Faruq M; Rajeshwari M; Singh M; Suri V; Sarkar C; Sharma MC
    J Neurooncol; 2018 May; 138(1):29-39. PubMed ID: 29354850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ependymoma-like tumor with mesenchymal differentiation (ELTMD) with ZFTA:NCOA1 fusion: A diagnostic challenge.
    Dorwal P; White C; Goh AF; Kumar A; McEniery J; Walker R; Robertson T
    Neuropathology; 2024 Jun; 44(3):216-221. PubMed ID: 37931917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors.
    Fukuoka K; Kanemura Y; Shofuda T; Fukushima S; Yamashita S; Narushima D; Kato M; Honda-Kitahara M; Ichikawa H; Kohno T; Sasaki A; Hirato J; Hirose T; Komori T; Satomi K; Yoshida A; Yamasaki K; Nakano Y; Takada A; Nakamura T; Takami H; Matsushita Y; Suzuki T; Nakamura H; Makino K; Sonoda Y; Saito R; Tominaga T; Matsusaka Y; Kobayashi K; Nagane M; Furuta T; Nakada M; Narita Y; Hirose Y; Ohba S; Wada A; Shimizu K; Kurozumi K; Date I; Fukai J; Miyairi Y; Kagawa N; Kawamura A; Yoshida M; Nishida N; Wataya T; Yamaoka M; Tsuyuguchi N; Uda T; Takahashi M; Nakano Y; Akai T; Izumoto S; Nonaka M; Yoshifuji K; Kodama Y; Mano M; Ozawa T; Ramaswamy V; Taylor MD; Ushijima T; Shibui S; Yamasaki M; Arai H; Sakamoto H; Nishikawa R; Ichimura K;
    Acta Neuropathol Commun; 2018 Dec; 6(1):134. PubMed ID: 30514397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion-Positive Supratentorial Ependymomas.
    Zheng T; Ghasemi DR; Okonechnikov K; Korshunov A; Sill M; Maass KK; Benites Goncalves da Silva P; Ryzhova M; Gojo J; Stichel D; Arabzade A; Kupp R; Benzel J; Taya S; Adachi T; Shiraishi R; Gerber NU; Sturm D; Ecker J; Sievers P; Selt F; Chapman R; Haberler C; Figarella-Branger D; Reifenberger G; Fleischhack G; Rutkowski S; Donson AM; Ramaswamy V; Capper D; Ellison DW; Herold-Mende CC; Schüller U; Brandner S; Driever PH; Kros JM; Snuderl M; Milde T; Grundy RG; Hoshino M; Mack SC; Gilbertson RJ; Jones DTW; Kool M; von Deimling A; Pfister SM; Sahm F; Kawauchi D; Pajtler KW
    Cancer Discov; 2021 Sep; 11(9):2230-2247. PubMed ID: 33879448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. epi-Aszonalenin B from Aspergillus novofumigatus inhibits NF-κB activity induced by ZFTA-RELA fusion protein that drives ependymoma.
    Ishikawa K; Ishii M; Yaguchi T; Katada T; Ichinose K; Ohata S
    Biochem Biophys Res Commun; 2022 Mar; 596():104-110. PubMed ID: 35131506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZFTA (Zinc Finger Translocation Associated) Fusion in Supratentorial Ependymomas: Low Prevalence in South Asians and No Correlation with Survival.
    Goyal-Honavar A; Balasundaram A; Thayakaran IP; Babu M; Pai R; Joseph J; Jayachandran R; Chacko AG; Mathew LG; Balakrishnan R; Rajshekhar V; Jeyaseelan L; Sudarsanam TD; Chacko G
    World Neurosurg; 2022 Aug; 164():e82-e90. PubMed ID: 35378317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI Phenotype of RELA-fused Pediatric Supratentorial Ependymoma.
    Nowak J; Jünger ST; Huflage H; Seidel C; Hohm A; Vandergrift LA; von Hoff K; Rutkowski S; Pietsch T; Warmuth-Metz M
    Clin Neuroradiol; 2019 Dec; 29(4):595-604. PubMed ID: 30027327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas.
    Tauziède-Espariat A; Nicaise Y; Sievers P; Sahm F; von Deimling A; Guillemot D; Pierron G; Duchesne M; Edjlali M; Dangouloff-Ros V; Boddaert N; Roux A; Dezamis E; Hasty L; Lhermitte B; Hirsch E; Hirsch MPV; Ardellier FD; Karnoub MA; Csanyi M; Maurage CA; Mokhtari K; Bielle F; Rigau V; Roujeau T; Abad M; Klein S; Bernier M; Horodyckid C; Adam C; Brandal P; Niehusmann P; Vannod-Michel Q; Provost C; de Champfleur NM; Nichelli L; Métais A; Mariet C; Chrétien F; Blauwblomme T; Beccaria K; Pallud J; Puget S; Uro-Coste E; Varlet P;
    Acta Neuropathol Commun; 2024 Apr; 12(1):55. PubMed ID: 38581034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ependymoma with C11orf95-MAML2 fusion: presenting with granular cell and ganglion cell features.
    Tamai S; Nakano Y; Kinoshita M; Sabit H; Nobusawa S; Arai Y; Hama N; Totoki Y; Shibata T; Ichimura K; Nakada M
    Brain Tumor Pathol; 2021 Jan; 38(1):64-70. PubMed ID: 33221956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional profiling of paediatric ependymomas identifies prognostically significant groups.
    Łastowska M; Matyja E; Sobocińska A; Wojtaś B; Niemira M; Szałkowska A; Krętowski A; Karkucińska-Więckowska A; Kaleta M; Ejmont M; Tarasińska M; Perek-Polnik M; Dembowska-Bagińska B; Pronicki M; Grajkowska W; Trubicka J
    J Pathol Clin Res; 2021 Nov; 7(6):565-576. PubMed ID: 34314101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of molecular signatures of supratentorial ependymomas.
    Torre M; Alexandrescu S; Dubuc AM; Ligon AH; Hornick JL; Meredith DM
    Mod Pathol; 2020 Jan; 33(1):47-56. PubMed ID: 31375768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular subgrouping of ependymoma across three anatomic sites and their prognostic implications.
    Chinnam D; Gupta K; Kiran T; Saraswati A; Salunke P; Madan R; Kumar N; Radotra BD
    Brain Tumor Pathol; 2022 Jul; 39(3):151-161. PubMed ID: 35348910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma.
    Cachia D; Wani K; Penas-Prado M; Olar A; McCutcheon IE; Benjamin RS; Armstrong TS; Gilbert MR; Aldape KD
    Brain Tumor Pathol; 2015 Apr; 32(2):105-11. PubMed ID: 25388523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma.
    Arabzade A; Zhao Y; Varadharajan S; Chen HC; Jessa S; Rivas B; Stuckert AJ; Solis M; Kardian A; Tlais D; Golbourn BJ; Stanton AJ; Chan YS; Olson C; Karlin KL; Kong K; Kupp R; Hu B; Injac SG; Ngo M; Wang PR; De León LA; Sahm F; Kawauchi D; Pfister SM; Lin CY; Hodges HC; Singh I; Westbrook TF; Chintagumpala MM; Blaney SM; Parsons DW; Pajtler KW; Agnihotri S; Gilbertson RJ; Yi J; Jabado N; Kleinman CL; Bertrand KC; Deneen B; Mack SC
    Cancer Discov; 2021 Sep; 11(9):2200-2215. PubMed ID: 33741710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Immunohistochemistry in the Identification of Supratentorial C11ORF95-RELA Fused Ependymoma in Routine Neuropathology.
    Gessi M; Giagnacovo M; Modena P; Elefante G; Gianno F; Buttarelli FR; Arcella A; Donofrio V; Diomedi Camassei F; Nozza P; Morra I; Massimino M; Pollo B; Giangaspero F; Antonelli M
    Am J Surg Pathol; 2019 Jan; 43(1):56-63. PubMed ID: 29266023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RELA Fusion in Supratentorial Extraventricular Ependymomas: A Morphologic, Immunohistochemical, and Molecular Study of 43 Cases.
    Wang L; Liu L; Li H; Wang P; Hu Z; Wei Y; Zhang M; Wen W; Li Z; Liu L; Zhao L; Lu D; Teng L
    Am J Surg Pathol; 2019 Dec; 43(12):1674-1681. PubMed ID: 31393268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.